Cargando…

Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression

T cell immunoglobulin mucin-3 (Tim-3) has previously been implicated in the immune response and tumor biology. Colorectal carcinoma (CRC) is a malignancy, which is closely associated with inflammation. However, the role of Tim-3 in the progression of CRC remains to be fully elucidated. The present s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Muming, Lu, Bin, Liu, Yancun, Me, Ying, Wang, Lijun, Zhang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364832/ https://www.ncbi.nlm.nih.gov/pubmed/28035413 http://dx.doi.org/10.3892/mmr.2016.6065

Ejemplares similares

Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis
por: Yu, Muming, et al.
Publicado: (2017)

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
por: Xu, Benling, et al.
Publicado: (2015)

Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
por: Wu, Zhengwei, et al.
Publicado: (2022)

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2013)

Cancer cell intrinsic TIM-3 induces glioblastoma progression
por: Guo, Qing, et al.
Publicado: (2022)

Tim-3 Expression Defines Regulatory T Cells in Human Tumors
por: Yan, Jing, et al.
Publicado: (2013)

Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2016)

Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2015)

TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
por: Gao, Xin, et al.
Publicado: (2012)

The effects of Tim-3 activation on T-cells in gastric cancer progression
por: Yu, Jiangtao, et al.
Publicado: (2019)

Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer
por: Kuai, Wentao, et al.
Publicado: (2020)

Upregulated Tim-3/galectin-9 expressions in acute lung injury in a murine malarial model
por: Liu, Jinfeng, et al.
Publicado: (2015)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

Tim-3 expression and its role in hepatocellular carcinoma
por: Liu, Feifei, et al.
Publicado: (2018)

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8(+) T cell dysfunction in melanoma patients
por: Fourcade, Julien, et al.
Publicado: (2010)

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma
por: Huang, Lili, et al.
Publicado: (2021)

TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal Cancer
por: Katagata, Masanori, et al.
Publicado: (2023)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
por: Nebbia, Gaia, et al.
Publicado: (2012)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation
por: Zang, Kui, et al.
Publicado: (2021)

On the significance of Tim-3 expression in pancreatic cancer
por: Peng, Pu-ji, et al.
Publicado: (2017)

Immune regulation by Tim-3
por: Banerjee, Hridesh, et al.
Publicado: (2018)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

TIGIT(+) TIM-3(+) NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
por: Yu, Lihua, et al.
Publicado: (2021)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2020)

An anti-tumor coup: TIM3 ablation activates the immune arsenal
por: Görgülü, Kıvanç, et al.
Publicado: (2021)

TIM-3: a tumor-associated antigen beyond checkpoint inhibition?
por: Barth, Stefan, et al.
Publicado: (2022)

FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer
por: Qiu, Junfeng, et al.
Publicado: (2022)

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
por: Zhang, Xingming, et al.
Publicado: (2019)

The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
por: Gonçalves Silva, Isabel, et al.
Publicado: (2016)

Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection
por: Wu, Wei, et al.
Publicado: (2011)

Regulation of Th1 T Cell Differentiation by Iron via Upregulation of T Cell Immunoglobulin and Mucin Containing Protein-3 (TIM-3)
por: Pfeifhofer-Obermair, Christa, et al.
Publicado: (2021)

TIM-3 expression in breast cancer
por: Burugu, Samantha, et al.
Publicado: (2018)

Tim Burton /
por: Marcos Arza, Marcos
Publicado: (2007)

Tim Lou
por: Lou, Hou Keong
Publicado: (2009)

Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
por: Kang, Chiao-Wen, et al.
Publicado: (2015)

Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients
por: Wang, Yong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tcf918gst33v2mn7ocbjjqcho1